Tounkara, F.; Sherpally, D.; Mumtaz, K.; Makary, M.S.; Palm, R.F.; Manne, A.
Immune Checkpoint Inhibitor Use in Advanced Hepatocellular Carcinoma: A Real-World Analysis of Efficacy and Toxicity. Cancers 2025, 17, 3034.
https://doi.org/10.3390/cancers17183034
AMA Style
Tounkara F, Sherpally D, Mumtaz K, Makary MS, Palm RF, Manne A.
Immune Checkpoint Inhibitor Use in Advanced Hepatocellular Carcinoma: A Real-World Analysis of Efficacy and Toxicity. Cancers. 2025; 17(18):3034.
https://doi.org/10.3390/cancers17183034
Chicago/Turabian Style
Tounkara, Fode, Deepak Sherpally, Khalid Mumtaz, Mina S. Makary, Russell F. Palm, and Ashish Manne.
2025. "Immune Checkpoint Inhibitor Use in Advanced Hepatocellular Carcinoma: A Real-World Analysis of Efficacy and Toxicity" Cancers 17, no. 18: 3034.
https://doi.org/10.3390/cancers17183034
APA Style
Tounkara, F., Sherpally, D., Mumtaz, K., Makary, M. S., Palm, R. F., & Manne, A.
(2025). Immune Checkpoint Inhibitor Use in Advanced Hepatocellular Carcinoma: A Real-World Analysis of Efficacy and Toxicity. Cancers, 17(18), 3034.
https://doi.org/10.3390/cancers17183034